Loading
IARC estimates 16,234 new cancer cases and 10,426 cancer deaths in Niger in 2024; the commonest new cancers are breast, liver and intrahepatic bile ducts and cervix uteri. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 3,581 | 48.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 2,230 | 16.7 | Hepatocellular carcinoma |
| Cervix uteri | 1,246 | 18.7 | Cervical cancer |
| Colorectum | 1,019 | 7.8 | Colorectal cancer |
| Ovary | 683 | 9.7 | Ovarian cancer |
| Stomach | 663 | 5.3 | Gastric & gastro-oesophageal junction cancer |
| Prostate | 623 | 13.0 | Prostate cancer |
| Bladder | 595 | 5.2 | Bladder & urothelial cancer |
| Pancreas | 532 | 4.4 | Pancreatic ductal adenocarcinoma |
| Kidney | 333 | 1.5 | Renal cell carcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 2,000 | 15.3 | Hepatocellular carcinoma |
| Breast | 1,708 | 23.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 755 | 11.5 | Cervical cancer |
| Colorectum | 560 | 4.5 | Colorectal cancer |
| Stomach | 508 | 4.3 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 506 | 4.3 | Pancreatic ductal adenocarcinoma |
| Ovary | 448 | 6.8 | Ovarian cancer |
| Prostate | 385 | 8.1 | Prostate cancer |
| Bladder | 352 | 3.3 | Bladder & urothelial cancer |
| Trachea, bronchus and lung | 250 | 2.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
No trial record in OnCo lists a site in Niger. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Niger.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Niger is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Niger is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.